Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Guangzhou Preterm and Term Birth Cohort Study (GPTBC)

30 ottobre 2026 aggiornato da: Li Cai, PhD, Sun Yat-sen University

The Guangzhou Preterm-Term Birth Cohort (GPTBC) is a prospective observational study of how early-life nutrition, environmental exposures, and family factors relate to the health and development of preterm and term infants and their mothers. Mother-infant pairs are followed from birth to 24 months. Researchers use questionnaires and biological samples to study human milk, microorganisms in the infant gut, physical growth, development, and allergic diseases, and whether these relationships differ between preterm and term infants. Findings may inform nutrition and health strategies for infants born at different gestational ages.

Panoramica dello studio

Stato

Attivo, non reclutante

Condizioni

Intervento / Trattamento

Descrizione dettagliata

The Guangzhou Preterm-Term Birth Cohort (GPTBC) is a single-center, prospective longitudinal observational study conducted at the Third Affiliated Hospital of Guangzhou Medical University. Mothers and their preterm or term infants were enrolled within 7 days after delivery and are followed primarily through 24 months of age; a subset receives additional follow-up beyond 24 months. The cohort was designed to recruit approximately equal numbers of preterm and term infants to characterize early-life exposures and health trajectories and to assess whether preterm birth modifies exposure-outcome associations.

The primary scientific focus is how human milk composition and other early-life nutritional and environmental exposures relate to infant growth, neuropsychological development, allergic diseases, and gut microbiome development. Serial human milk samples support measurements of nutritional components, 23 targeted human milk oligosaccharides, selected bioactive proteins, fatty acids, metabolomic and lipidomic profiles, microbial metagenomes, and exposomic profiles of environmental contaminants. Infant stool samples are analyzed using metagenomic sequencing. Additional stored biospecimens support related current and future research.

Repeated questionnaires capture maternal postpartum health, diet, lifestyle, psychological status, medication use, and breastfeeding; infant feeding, supplementation, illness, medication use, sleep, activity, screen exposure, and caregiving environment; and selected paternal and family characteristics. Child health is assessed longitudinally using anthropometry, standardized developmental assessments, eye tracking, parental reports of physician-diagnosed allergic diseases, and microbiome measures.

The study will examine exposure patterns and their changes over time, associations with maternal and child health, potential biological pathways, and differences between preterm and term infants.

Tipo di studio

Osservativo

Iscrizione (Stimato)

200

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Luoghi di studio

    • Guangdong
      • Guangzhou, Guangdong, Cina, 510000
        • Sun Yat-sen University

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

Da 18 anni a 45 anni (Adulto)

Accetta volontari sani

Sì

Sessi ammissibili allo studio

Tutto

Metodo di campionamento

Campione non probabilistico

Popolazione di studio

Mother-infant pairs (term and preterm).

Descrizione

Inclusion Criteria:

  1. Maternal age between 18 and 45 years.
  2. Resident in Guangzhou for at least one year.
  3. Gestational age at delivery ≥ 32 weeks and < 42 weeks (moderate-to-late preterm or term births).

Exclusion Criteria:

  1. Critical illness during pregnancy requiring admission to the intensive care unit.
  2. Unwilling or unable to breastfeed.

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Modelli osservazionali: COHORT
  • Prospettive temporali: PROSPECTIVE

Coorti e interventi

Gruppo / Coorte
Intervento / Trattamento
Preterm Birth Group

Mother-infant pairs in which the infant was born at 32 weeks 0 days to 36 weeks 6 days of gestation.

This cohort study have any no intervention.

Term Birth Group

Mother-infant pairs in which the infant was born at 37 weeks 0 days to 41 weeks 6 days of gestation.

This cohort study have any no intervention.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Offspring Length/Height (cm)
Lasso di tempo: Birth, 1 months, 3 months, 6 months, 8 months, 12 months, 18 months, and 24 months of age.

Offspring length or height measured by a pediatrician.

Birth, 1 months, 3 months, 6 months, 8 months, 12 months, 18 months, and 24 months of age.
Offspring Weight (kg)
Lasso di tempo: Birth, 1 month, 3 months, 6 months, 8 months, 12 months, 18 months, 24 months of age.

Offspring weight measured using a calibrated scale.

Birth, 1 month, 3 months, 6 months, 8 months, 12 months, 18 months, 24 months of age.
Offspring Head Circumference (cm)
Lasso di tempo: Birth, 1 month, 3 months, 6 months, 8 months, 12 months, 18 months, 24 months of age.

Offspring head circumference measured by a pediatrician.

Birth, 1 month, 3 months, 6 months, 8 months, 12 months, 18 months, 24 months of age.
Offspring Body Mass Index (kg/m²)
Lasso di tempo: Birth, 1 month, 3 months, 6 months, 8 months, 12 months, 18 months, 24 months of age.

Calculated as weight (kg) divided by the square of length or height (in meters).

Birth, 1 month, 3 months, 6 months, 8 months, 12 months, 18 months, 24 months of age.
Neurodevelopmental outcome - Gesell Developmental Schedules (GDS)
Lasso di tempo: 1 month, 3 months, 6 months, 8 months, 12 months, 18 months, and 24 months of age.

Developmental Quotients (DQ) for each developmental domain, assessed by the Gesell Developmental Schedules (GDS) administered by a pediatrician. DQ is calculated as (developmental age / chronological age or corrected age) × 100, with higher DQ indicating better development. Domains include: (1) adaptive, (2) gross motor, (3) fine motor, (4) language, and (5) personal-social.

1 month, 3 months, 6 months, 8 months, 12 months, 18 months, and 24 months of age.
Neurodevelopmental outcome - Ages and Stages Questionnaires (ASQ)
Lasso di tempo: 1 month, 3 months, 6 months, 8 months, 12 months, 18 months, 24 months of age.

Parent-reported scores (0-60) for each developmental domain, assessed using the Ages and Stages Questionnaires (ASQ). Higher scores indicate better development. Domains include: (1) communication, (2) gross motor, (3) fine motor, (4) problem-solving, and (5) personal-social.

1 month, 3 months, 6 months, 8 months, 12 months, 18 months, 24 months of age.

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Social Cognitive Attention Patterns - Sufficient Fixation Trials (number)
Lasso di tempo: 6 months, 8 months, and 12 months of age.

Number of trials in which the fixation duration on specific Areas of Interest (social and non-social) exceeds 30% of the total fixation duration on the entire screen, measured using a Tobii Pro Spectrum eye-tracker across biological motion, joint attention, and visual preference paradigms. This eye-tracking indicator indicates adequate attentional engagement with the presented social and non-social stimuli.

6 months, 8 months, and 12 months of age.
Social Cognitive Attention Patterns - First Fixation Count (number)
Lasso di tempo: 6 months, 8 months, 12 months of age.

Number of times the first fixation following stimuli onset lands on specific Areas of Interest (social and non-social), measured using a Tobii Pro Spectrum eye-tracker across biological motion, joint attention, and visual preference paradigms. This eye-tracking indicator captures initial attentional orienting and reflects the salience of the presented social and non-social stimuli.

6 months, 8 months, 12 months of age.
Social Cognitive Attention Patterns - First Fixation Duration (seconds)
Lasso di tempo: 6 months, 8 months, 12 months of age.

Duration (in seconds) of the first fixation within specific Areas of Interest (social and non-social) following stimulus onset, measured using a Tobii Pro Spectrum eye-tracker across biological motion, joint attention, and visual preference paradigms. This eye-tracking indicator reflects early-stage attentional processing and the efficiency of initial stimulus engagement.

6 months, 8 months, 12 months of age.
Social Cognitive Attention Patterns - Total Fixation Count (number)
Lasso di tempo: 6 months, 8 months, 12 months of age.

Total number of discrete fixation events occurring within specific Areas of Interest (social and non-social), measured using a Tobii Pro Spectrum eye-tracker across biological motion, joint attention, and visual preference paradigms. This eye-tracking indicator reflects the overall frequency of attentional engagement with the presented social and non-social stimuli.

6 months, 8 months, 12 months of age.
Social Cognitive Attention Patterns - Total Fixation Duration (seconds)
Lasso di tempo: 6 months, 8 months, 12 months of age.

Cumulative duration (in seconds) of all fixations occurring within specific Areas of Interest (social and non-social), measured using a Tobii Pro Spectrum eye-tracker across biological motion, joint attention, and visual preference paradigms. This eye-tracking indicator reflects overall attentional allocation to the presented social and non-social stimuli.

6 months, 8 months, 12 months of age.
Social Cognitive Attention Patterns - Fixation Duration Proportion (%)
Lasso di tempo: 6 months, 8 months, 12 months of age.

Percentage of total fixation time allocated to social or non-social Areas of Interest, calculated as (total fixation time on social or non-social Areas of Interest / total fixation time on all Areas of Interest) × 100, measured using a Tobii Pro Spectrum eye-tracker across biological motion, joint attention, and visual preference paradigms. This eye-tracking indicator reflects relative attentional preference between social and non-social stimuli.

6 months, 8 months, 12 months of age.
Number of Participants with Physician-Diagnosed Allergic Diseases
Lasso di tempo: 1 month, 3 months, 6 months, 8 months, 12 months, 18 months, 24 months of age.

Number of participants who experience at least one episode of physician-diagnosed allergic diseases during the follow-up period, including eczema or atopic dermatitis, cow's milk protein allergy, other food allergies, allergic rhinitis, and asthma, as diagnosed by a physician and reported by parents, and confirmed by medical records.

1 month, 3 months, 6 months, 8 months, 12 months, 18 months, 24 months of age.

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Sponsor

Collaboratori

Investigatori

  • Investigatore principale: Li Cai, Ph.D, Sun Yat-sen University
  • Investigatore principale: Lizi Lin, Ph.D, Sun Yat-sen University

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

21 novembre 2023

Completamento primario (Stimato)

31 dicembre 2026

Completamento dello studio (Stimato)

31 dicembre 2026

Date di iscrizione allo studio

Primo inviato

14 aprile 2026

Primo inviato che soddisfa i criteri di controllo qualità

5 agosto 2026

Primo Inserito (Effettivo)

10 agosto 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

3 novembre 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

30 ottobre 2026

Ultimo verificato

1 ottobre 2026

Maggiori informazioni

Termini relativi a questo studio

Altri numeri di identificazione dello studio

  • GPTBC

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

INDECISO

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .